MATTERHORN trial finds TEER non-inferior to surgery for secondary mitral regurgitation

There was no difference in efficacy between transcatheter edge-to-edge repair (TEER) and surgery in patients with secondary mitral regurgitation (MR), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Abnormal BMI in children linked to impaired lung function

An abnormal BMI in children – be it high or low – can now be associated with impaired lung function, but if their BMI is

October 28, 2024

Bausch + Lomb considers sale: FT

Dive Brief: Bausch + Lomb is exploring a potential sale that would separate the eye care company from parent firm Bausch Health, the Financial Times

September 16, 2024

NICE not to recommend Daiichi Sankyo-AstraZeneca’s Enhertu

NICE will reconsider Enhertu under its rapid review process, subject to the companies agreeing to lower the price. Credit: NICE. The UK National Institute for

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.